Stock listing
NASDAQ:HURA TuHURA Biosciences, Inc. Stock
Home listing (NASDAQ) of TuHURA Biosciences, Inc.
Follow TuHURA Biosciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:HURA
$1.72 USD -0.21 (-10.9%)
Close on Nov 2, 2026
- Day range
- $1.70 – $1.99 USDNov 2, 2026
- Volume
- 640,792 sharesNov 2, 2026
- Market cap
- $109.6M USDAt the close on Nov 2, 2026 · price × 63.73M shares outstanding
- 52-week range
- $0.41 – $3.43 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $586,166 USDMedian day 199,600 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HURA · Home | $1.72 USD | -0.21 (-10.9%) | 640,792 | $1.99 | $1.99 | $1.70 | $1.93 | Close on Nov 2, 2026 |
| Frankfurt:PL3 | €1.84 EUR | +0.04 (+2.2%) | — | €1.84 | €1.84 | €1.84 | €1.80 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:HURA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.72 | -0.21 | -10.9% | $1.99 | $1.99 | $1.70 | 640,792 | |
| $1.93 | -0.13 | -6.3% | $2.01 | $2.03 | $1.85 | 518,638 | |
| $2.06 | +0.07 | +3.5% | $2.028 | $2.08 | $1.98 | 295,389 | |
| $1.99 | -0.12 | -5.7% | $2.08 | $2.12 | $1.93 | 566,741 | |
| $2.11 | +0.07 | +3.4% | $2.05 | $2.12 | $1.99 | 398,091 | |
| $2.04 | -0.14 | -6.4% | $2.205 | $2.23 | $1.93 | 634,836 | |
| $2.18 | +0.17 | +8.5% | $2.07 | $2.185 | $2.05 | 1,013,965 | |
| $2.01 | -0.075 | -3.6% | $2.20 | $2.20 | $1.96 | 609,256 | |
| $2.085 | +0.325 | +18.5% | $1.74 | $2.11 | $1.71 | 1,079,419 | |
| $1.76 | -0.02 | -1.1% | $1.77 | $1.81 | $1.75 | 39,147 | |
| $1.78 | +0.02 | +1.1% | $1.75 | $1.96 | $1.74 | 173,436 | |
| $1.76 | -0.07 | -3.8% | $1.81 | $1.85 | $1.76 | 86,000 | |
| $1.83 | +0.07 | +4.0% | $1.74 | $1.84 | $1.74 | 86,400 | |
| $1.76 | -0.05 | -2.8% | $1.78 | $1.78 | $1.711 | 145,000 | |
| $1.81 | -0.09 | -4.7% | $1.91 | $1.91 | $1.80 | 354,300 | |
| $1.90 | -0.06 | -3.1% | $1.97 | $1.99 | $1.89 | 170,300 | |
| $1.96 | +0.03 | +1.6% | $1.95 | $1.99 | $1.95 | 149,000 | |
| $1.93 | -0.05 | -2.5% | $1.95 | $1.97 | $1.89 | 316,200 | |
| $1.98 | +0.03 | +1.5% | $1.91 | $2.00 | $1.871 | 140,200 | |
| $1.95 | +0.08 | +4.3% | $1.90 | $1.98 | $1.87 | 181,700 | |
| $1.87 | -0.04 | -2.1% | $1.94 | $1.94 | $1.85 | 334,300 | |
| $1.91 | -0.07 | -3.5% | $2.00 | $2.05 | $1.88 | 287,700 | |
| $1.98 | -0.12 | -5.7% | $2.09 | $2.10 | $1.97 | 273,600 | |
| $2.10 | +0.03 | +1.4% | $2.06 | $2.175 | $2.06 | 284,500 | |
| $2.07 | -0.02 | -1.0% | $2.08 | $2.12 | $2.035 | 231,000 | |
| $2.09 | -0.01 | -0.5% | $2.06 | $2.16 | $2.03 | 375,400 | |
| $2.10 | 0.00 | 0.0% | $2.14 | $2.15 | $2.045 | 149,300 | |
| $2.10 | +0.05 | +2.4% | $2.04 | $2.125 | $2.03 | 194,500 | |
| $2.05 | -0.08 | -3.8% | $2.10 | $2.10 | $2.04 | 185,000 | |
| $2.13 | -0.05 | -2.3% | $2.17 | $2.22 | $2.10 | 251,700 | |
| $2.18 | +0.08 | +3.8% | $2.06 | $2.19 | $2.06 | 237,200 | |
| $2.10 | +0.01 | +0.5% | $2.11 | $2.14 | $2.07 | 174,700 | |
| $2.09 | +0.06 | +3.0% | $2.05 | $2.10 | $2.04 | 195,800 | |
| $2.03 | 0.00 | 0.0% | $2.03 | $2.103 | $2.01 | 108,100 | |
| $2.03 | -0.02 | -1.0% | $2.05 | $2.05 | $1.98 | 132,100 | |
| $2.05 | 0.00 | 0.0% | $2.05 | $2.16 | $2.05 | 167,300 | |
| $2.05 | +0.02 | +1.0% | $2.05 | $2.10 | $2.04 | 113,900 | |
| $2.03 | +0.02 | +1.0% | $2.01 | $2.06 | $1.98 | 286,000 | |
| $2.01 | -0.11 | -5.2% | $2.12 | $2.15 | $2.00 | 148,900 | |
| $2.12 | -0.02 | -0.9% | $2.15 | $2.18 | $2.05 | 314,900 | |
| $2.14 | +0.04 | +1.9% | $2.09 | $2.155 | $2.06 | 367,800 | |
| $2.10 | +0.01 | +0.5% | $2.13 | $2.13 | $2.04 | 107,100 | |
| $2.09 | +0.06 | +3.0% | $2.03 | $2.09 | $2.005 | 139,100 | |
| $2.03 | -0.10 | -4.7% | $2.11 | $2.13 | $2.03 | 152,800 | |
| $2.13 | +0.02 | +0.9% | $2.12 | $2.23 | $2.075 | 233,400 | |
| $2.11 | -0.02 | -0.9% | $2.15 | $2.15 | $2.04 | 99,700 | |
| $2.13 | 0.00 | 0.0% | $2.14 | $2.15 | $2.10 | 100,000 | |
| $2.13 | +0.09 | +4.4% | $2.03 | $2.135 | $2.03 | 158,700 | |
| $2.04 | -0.11 | -5.1% | $2.14 | $2.19 | $2.03 | 239,400 | |
| $2.15 | +0.15 | +7.5% | $2.10 | $2.195 | $2.03 | 143,200 | |
| $2.00 | -0.22 | -9.9% | $2.26 | $2.26 | $1.99 | 385,000 | |
| $2.22 | -0.06 | -2.6% | $2.26 | $2.31 | $2.20 | 148,500 | |
| $2.28 | +0.12 | +5.6% | $2.17 | $2.31 | $2.16 | 158,300 | |
| $2.16 | -0.12 | -5.3% | $2.32 | $2.379 | $2.145 | 304,100 | |
| $2.28 | -0.19 | -7.7% | $2.42 | $2.48 | $2.275 | 517,000 | |
| $2.47 | +0.17 | +7.4% | $2.29 | $2.49 | $2.22 | 317,100 | |
| $2.30 | -0.04 | -1.7% | $2.40 | $2.58 | $2.29 | 522,300 | |
| $2.34 | +0.04 | +1.7% | $2.31 | $2.52 | $2.28 | 646,500 | |
| $2.30 | +0.15 | +7.0% | $2.17 | $2.40 | $2.115 | 676,800 | |
| $2.15 | +0.02 | +0.9% | $2.15 | $2.22 | $2.12 | 183,300 | |
| $2.13 | +0.015 | +0.7% | $2.15 | $2.15 | $2.08 | 66,700 | |
| $2.115 | +0.025 | +1.2% | $2.08 | $2.15 | $2.07 | 88,200 | |
| $2.09 | 0.00 | 0.0% | $2.13 | $2.14 | $2.04 | 132,900 | |
| $2.09 | -0.05 | -2.3% | $2.15 | $2.18 | $2.083 | 199,600 | |
| $2.14 | -0.03 | -1.4% | $2.20 | $2.22 | $2.12 | 208,000 |
- Ticker
- NASDAQ:HURA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
TuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line Treatment of Patients with Deep Seated Metastatic Merkel Cell Carcinoma
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 24 slides
Calls
Replays
CohBar, Inc. (CWBR) Q3 2022 Earnings Call
Tue, Nov 08, 2022 · 5:00 PM ET
Watch TranscriptCohBar, Inc. (CWBR) Q2 2022 Earnings Call
Mon, Aug 15, 2022 · 8:00 PM ET
Watch TranscriptCohBar, Inc. (CWBR) Q1 2022 Earnings Call
Mon, May 16, 2022 · 5:00 PM ET
Watch Transcript
Latest news
TuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line Treatment of Patients with Deep Seated Metastatic Merkel Cell Carcinoma
Oct 26, 2026
Closed $2.04 (-6.4%) on Oct 26, 2026
TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025
Oct 13, 2026
Closed $1.81 (-4.7%) on Oct 13, 2026
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology
Oct 5, 2026
Closed $1.87 (-2.1%) on Oct 5, 2026
TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood-Related Cancers
Sep 14, 2026
Closed $2.05 (0.0%) on Sep 14, 2026
TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $2.12 (-0.9%) on Sep 8, 2026
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Aug 14, 2026
Closed $2.47 (+7.4%) on Aug 14, 2026
TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
Jul 22, 2026
Closed $2.24 (+1.4%) on Jul 22, 2026
TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 15, 2026
Closed $2.55 (+10.4%) on May 18, 2026
TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
May 12, 2026
Closed $2.42 (+0.8%) on May 12, 2026
TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028
Apr 22, 2026
Closed $2.68 (-3.6%) on Apr 22, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 24 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 23 slides · May 15, 2026
Investor Presentation (March 2026)
Investor deck · 23 slides · March 2026
Investor Presentation (January 2026)
Investor deck · 29 slides · January 2026
TuHURA Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 70 in all · newest Oct 26, 2026 · oldest 2022
- Calls
- 5 calls with a replay · 5 with a transcript · latest Nov 8, 2022
- Decks
- 7 decks · latest August 2026
Where TuHURA Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HURA · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A3EWMJ | LS Exchange | Germany | EUR |
| gettex:PL3 | gettex | Germany | EUR |
| Lang & Schwarz:A3EWMJ | Lang & Schwarz | Germany | EUR |
| BOATS:HURA | BOATS | United States | USD |
| Tradegate:PL3 | Tradegate | Germany | EUR |
| Frankfurt:PL3 | Frankfurt | Germany | EUR |
| Munich:PL3 | Munich | Germany | EUR |
| Stuttgart:PL3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about TuHURA Biosciences, Inc.